Alzheimer's Association International Conference 2020
The Alzheimer's Association International Conference, held virtually from July 27-31, 2020m is where international investigators, clinicians and care providers gather to share the latest study results, theories, and discoveries that will help bring the world closer to breakthroughs in dementia science.
The director of the Memory Disorders Program and professor of neurology at Georgetown University Medical Center details his findings from the phase 2 study of nilotinib in patients with Alzheimer disease.
The postdoctoral fellow at the University of Miami Miller School of Medicine detailed her study presented at AAIC 2020 that examined Alzheimer risk associated with APOE ε4 in different genetic populations.
Compared to treatment with lisinopril, those treated with the angiotensin receptor blocker candesartan showed improvements on the Trial Making Test part A and B and Hopkins Verbal Learning Test-Revised delayed recall.